On Oct. 18, 2018, AbbVie and Morphic Therapeutic, a biotechnology company developing oral integrin therapies, announced that they have entered …
On Oct. 18, 2018, AbbVie and Morphic Therapeutic, a biotechnology company developing oral integrin therapies, announced that they have entered …